10:20–11:05am ET
Non-CME Industry Theater
Shifting Perspectives: How Do You Choose the Next Oral Therapy for T2D?
Sponsored by Novo Nordisk Inc.
Non-CME Industry Theater
Evaluating the Use of Oral Corticosteroids in Asthma: Benefits and Risks
Sponsored by AstraZeneca Pharmaceuticals, LP
1:35–2:20pm ET
Non-CME Industry Theater
Discover the Impact of GEMTESA: A Selective β3-Adrenergic Agonist for Effective OAB Treatment
Sponsored by Urovant Sciences
Non-CME Industry Theater
Two Oral CGRP Antagonists for the Treatment of Migraine
Sponsored by AbbVie
4:50–5:35pm ET
Non-CME Industry Theater
Clinical Considerations in Coronary Artery Disease
Sponsored by AstraZeneca Pharmaceuticals, LP
10:20–11:05am ET
Non-CME Industry Theater
Rethinking the Role of Nebulization in the Maintenance Treatment of COPD
Sponsored by Viatris and Theravance Biopharma
Non-CME Industry Theater
Treating EPI: EPI in Clinical Practice
Sponsored by AbbVie
1:35–2:20pm ET
Non-CME Industry Theater
Clinical Insights in Reducing Major Thrombotic Vascular Events in Patients With PAD
Sponsored by Janssen Pharmaceuticals, Inc.
Non-CME Industry Theater
The Changing Treatment Landscape for Uncontrolled Asthma
Sponsored by GlaxoSmithKline
4:50–5:35pm ET
Non-CME Industry Theater
Path To Diagnosis, Mapping Symptoms of Inflammatory Back Pain
Sponsored by AbbVie Inc.